Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent
to the standard of care pain protocol for postoperative pain control following ACL
reconstruction surgery.
2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the
standard of care pain protocol will reduce postoperative opioid consumption following
ACL reconstruction surgery.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Treatments:
Acetaminophen Acetaminophen, hydrocodone drug combination Ketorolac Ketorolac Tromethamine Oxycodone